retatrutide clinical trials news ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Trial of next-gen weight-loss drug

Many promising biomarkers identified in small studies fail to replicate in larger validation cohorts

Point-of-care gastric ultrasound has become a valuable tool that identifies patients with higher aspiration risk [35]

Before you buy (recommended reading): Most bad experiences reported with peptides come down to dosing, handling, legality, or purity, not just the compounds themselves

For instance, choosing Sunday morning or Wednesday evening and maintaining that schedule reduces the likelihood of missed doses

The difference is that compounded medications are not manufactured by the original drug company and are not FDA-approved as finished products, though they are legal under specific pharmacy regulations